It has been demonstrated that FGF18 regulates both tumor cells and tumor microenvironment to facilitate the progression of serous ovarian cancer, enhancing angiogenesis and tumor-associated macrophage infiltration [69, 88]. The gene discussed is FGF18; the disease is ovarian serous adenocarcinoma.